Hyperlipidemia Trials in Miami, United States
Conditions / Hyperlipidemia / Miami, United States
Hyperlipidemia has been the subject of sustained clinical investigation across multiple research sites.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00108485 | Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy | TERMINATED | PHASE3 |
| NCT01763827 | Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 | COMPLETED | PHASE3 |
| NCT01968967 | Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT02100514 | Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT00267267 | A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. | TERMINATED | PHASE3 |
| NCT00109603 | Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy | COMPLETED | NA |
| NCT00134173 | A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease | COMPLETED | PHASE3 |
| NCT01763866 | LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 | COMPLETED | PHASE3 |
| NCT01968954 | Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT00663234 | IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia | TERMINATED | PHASE1/PHASE2 |